Analystreport

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) had its price target raised by analysts at Piper Sandler from $40.00 to $47.00.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com